198 related articles for article (PubMed ID: 33654176)
1. A single-chain antibody generation system yielding CAR-T cells with superior antitumor function.
Ochi T; Maruta M; Tanimoto K; Kondo F; Yamamoto T; Kurata M; Fujiwara H; Masumoto J; Takenaka K; Yasukawa M
Commun Biol; 2021 Mar; 4(1):273. PubMed ID: 33654176
[TBL] [Abstract][Full Text] [Related]
2. Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization.
Hanssens H; Meeus F; De Vlaeminck Y; Lecocq Q; Puttemans J; Debie P; De Groof TWM; Goyvaerts C; De Veirman K; Breckpot K; Devoogdt N
Front Immunol; 2024; 15():1389018. PubMed ID: 38720898
[TBL] [Abstract][Full Text] [Related]
3. Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression.
Gacerez AT; Hua CK; Ackerman ME; Sentman CL
Cancer Immunol Immunother; 2018 May; 67(5):749-759. PubMed ID: 29453518
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of a novel CAR-T therapy utilizing a scFv antibody highly specific to MAGE-A4
Wang L; Matsumoto M; Akahori Y; Seo N; Shirakura K; Kato T; Katsumoto Y; Miyahara Y; Shiku H
Mol Ther; 2024 Mar; 32(3):734-748. PubMed ID: 38243600
[TBL] [Abstract][Full Text] [Related]
5. Tuning the ignition of CAR: optimizing the affinity of scFv to improve CAR-T therapy.
Duan Y; Chen R; Huang Y; Meng X; Chen J; Liao C; Tang Y; Zhou C; Gao X; Sun J
Cell Mol Life Sci; 2021 Dec; 79(1):14. PubMed ID: 34966954
[TBL] [Abstract][Full Text] [Related]
6. Rapid In Vitro Cytotoxicity Evaluation of Jurkat Expressing Chimeric Antigen Receptor using Fluorescent Imaging.
Subham S; Jeppson JD; Gibbs BK; Babai J; Alker R; Godwin AK; Akhavan D
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37955379
[TBL] [Abstract][Full Text] [Related]
7. Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer.
Chen J; Zhu T; Jiang G; Zeng Q; Li Z; Huang X
Mol Cancer; 2023 Aug; 22(1):131. PubMed ID: 37563723
[TBL] [Abstract][Full Text] [Related]
8. CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity.
Sauer T; Parikh K; Sharma S; Omer B; Sedloev D; Chen Q; Angenendt L; Schliemann C; Schmitt M; Müller-Tidow C; Gottschalk S; Rooney CM
Blood; 2021 Jul; 138(4):318-330. PubMed ID: 34323938
[TBL] [Abstract][Full Text] [Related]
9. The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment.
Xiong Q; Wang H; Shen Q; Wang Y; Yuan X; Lin G; Jiang P
J Transl Med; 2024 Apr; 22(1):368. PubMed ID: 38637886
[TBL] [Abstract][Full Text] [Related]
10. GXMR-CAR containing distinct GXM-specific single-chain variable fragment (scFv) mediated the cell activation against
Machado MP; Dos Santos MH; Guimarães JG; de Campos GY; Oliveira Brito PKM; Ferreira CMG; Rezende CP; Frota NF; Soares SG; Kumaresan PR; Lourenzoni MR; da Silva TA
Bioengineered; 2023 Dec; 14(1):2281059. PubMed ID: 37978838
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterisation of novel CAR-T cells to target IL13Rα2 positive human glioma in vitro and in vivo.
Leland P; Degheidy H; Lea A; Bauer SR; Puri RK; Joshi BH
Clin Transl Med; 2024 May; 14(5):e1664. PubMed ID: 38685487
[TBL] [Abstract][Full Text] [Related]
12. Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with
Leland P; Kumar D; Nimmagadda S; Bauer SR; Puri RK; Joshi BH
J Transl Med; 2023 Jun; 21(1):367. PubMed ID: 37286997
[TBL] [Abstract][Full Text] [Related]
13. Humanized single-domain antibody targeting HER2 enhances function of chimeric antigen receptor T cells.
Zheng R; Chen Y; Zhang Y; Liang S; Zhao X; Wang Y; Wang P; Meng R; Yang A; Yan B
Front Immunol; 2023; 14():1258156. PubMed ID: 38022548
[TBL] [Abstract][Full Text] [Related]
14. Synthetic promoters to induce immune-effectors into the tumor microenvironment.
Greenshpan Y; Sharabi O; Ottolenghi A; Cahana A; Kundu K; M Yegodayev K; Elkabets M; Gazit R; Porgador A
Commun Biol; 2021 Jan; 4(1):143. PubMed ID: 33514819
[TBL] [Abstract][Full Text] [Related]
15. Complementarity-determining region clustering may cause CAR-T cell dysfunction.
Sarén T; Saronio G; Marti Torrell P; Zhu X; Thelander J; Andersson Y; Hofström C; Nestor M; Dimberg A; Persson H; Ramachandran M; Yu D; Essand M
Nat Commun; 2023 Aug; 14(1):4732. PubMed ID: 37563127
[TBL] [Abstract][Full Text] [Related]
16. Methods of Machine Learning-Based Chimeric Antigen Receptor Immunological Synapse Quality Quantification.
Gan J; Cho JH; Lee R; Naghizadeh A; Poon LY; Wang E; Hui Z; Liu D
Methods Mol Biol; 2023; 2654():493-502. PubMed ID: 37106203
[TBL] [Abstract][Full Text] [Related]
17. Hyperstabilization of T cell microvilli contacts by chimeric antigen receptors.
Beppler C; Eichorst J; Marchuk K; Cai E; Castellanos CA; Sriram V; Roybal KT; Krummel MF
J Cell Biol; 2023 Mar; 222(3):. PubMed ID: 36520493
[TBL] [Abstract][Full Text] [Related]
18. Antibody variable region engineering for improving cancer immunotherapy.
Lou H; Cao X
Cancer Commun (Lond); 2022 Sep; 42(9):804-827. PubMed ID: 35822503
[TBL] [Abstract][Full Text] [Related]
19. Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications.
Favalli N; Bassi G; Pellegrino C; Millul J; De Luca R; Cazzamalli S; Yang S; Trenner A; Mozaffari NL; Myburgh R; Moroglu M; Conway SJ; Sartori AA; Manz MG; Lerner RA; Vogt PK; Scheuermann J; Neri D
Nat Chem; 2021 Jun; 13(6):540-548. PubMed ID: 33833446
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
